429 related articles for article (PubMed ID: 25627160)
1. Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid.
Nicolini C; Ahn Y; Michalski B; Rho JM; Fahnestock M
Acta Neuropathol Commun; 2015 Jan; 3():3. PubMed ID: 25627160
[TBL] [Abstract][Full Text] [Related]
2. PI3K/AKT/mTOR-mediated autophagy in the development of autism spectrum disorder.
Zhang J; Zhang JX; Zhang QL
Brain Res Bull; 2016 Jul; 125():152-8. PubMed ID: 27320472
[TBL] [Abstract][Full Text] [Related]
3. Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice.
Yamaguchi H; Hara Y; Ago Y; Takano E; Hasebe S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Behav Brain Res; 2017 Aug; 333():67-73. PubMed ID: 28655565
[TBL] [Abstract][Full Text] [Related]
4. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
Zhang Y; Xiang Z; Jia Y; He X; Wang L; Cui W
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109644. PubMed ID: 31075347
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats.
Qin L; Dai X; Yin Y
Mol Cell Neurosci; 2016 Sep; 75():27-35. PubMed ID: 27343825
[TBL] [Abstract][Full Text] [Related]
6. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of valproic acid-induced dendritic spine and synaptic impairment in the prefrontal cortex for causing core autistic symptoms in mice].
Wang F; Wang L; Xiong Y; Deng J; Lü M; Tang B; Zhang X; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):101-107. PubMed ID: 35249876
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
9. Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero.
Kotajima-Murakami H; Kobayashi T; Kashii H; Sato A; Hagino Y; Tanaka M; Nishito Y; Takamatsu Y; Uchino S; Ikeda K
Mol Brain; 2019 Jan; 12(1):3. PubMed ID: 30621732
[TBL] [Abstract][Full Text] [Related]
10. The antidepressant-like effect of alarin is related to TrkB-mTOR signaling and synaptic plasticity.
Zhuang F; Li M; Gao X; Wang Y; Wang D; Ma X; Ma T; Gu S
Behav Brain Res; 2016 Oct; 313():158-171. PubMed ID: 27374162
[TBL] [Abstract][Full Text] [Related]
11. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder.
Jernigan CS; Goswami DB; Austin MC; Iyo AH; Chandran A; Stockmeier CA; Karolewicz B
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1774-9. PubMed ID: 21635931
[TBL] [Abstract][Full Text] [Related]
12. Perinatal exposure to BDE-47 exacerbated autistic-like behaviors and impairments of dendritic development in a valproic acid-induced rat model of autism.
Li Z; You M; Che X; Dai Y; Xu Y; Wang Y
Ecotoxicol Environ Saf; 2021 Apr; 212():112000. PubMed ID: 33550075
[TBL] [Abstract][Full Text] [Related]
13. mTOR signalling pathway - A root cause for idiopathic autism?
Ganesan H; Balasubramanian V; Iyer M; Venugopal A; Subramaniam MD; Cho SG; Vellingiri B
BMB Rep; 2019 Jul; 52(7):424-433. PubMed ID: 31186084
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family.
Poopal AC; Schroeder LM; Horn PS; Bassell GJ; Gross C
Mol Autism; 2016; 7():3. PubMed ID: 26770665
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
[TBL] [Abstract][Full Text] [Related]
18. Tactile stimulation improves neuroanatomical pathology but not behavior in rats prenatally exposed to valproic acid.
Raza S; Harker A; Richards S; Kolb B; Gibb R
Behav Brain Res; 2015 Apr; 282():25-36. PubMed ID: 25557797
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide Exposure Induces Maternal Hypozincemia, and Prenatal Zinc Treatment Prevents Autistic-Like Behaviors and Disturbances in the Striatal Dopaminergic and mTOR Systems of Offspring.
Kirsten TB; Chaves-Kirsten GP; Bernardes S; Scavone C; Sarkis JE; Bernardi MM; Felicio LF
PLoS One; 2015; 10(7):e0134565. PubMed ID: 26218250
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
